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Small heat shock proteins have been the Cinderellas of
the molecular chaperone world, but now the crystal
structure of a small heat shock protein has been solved
and mutation of two human homologues implicated in
genetic disease. Intermediate filaments appear to be
one of the key targets of their chaperone activity.
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In recent years there has been intense interest in the
molecular chaperones that assist protein folding, transloca-
tion and assembly inside cells. The best-known molecular
chaperones were initially identified as heat shock proteins,
which accumulate to a higher level in cells exposed to a
heat shock and protect cells against stress. One large
family of heat shock proteins has remained relatively
poorly understood — these are the small heat shock pro-
teins, a family of proteins with a molecular weight gene-
rally less than 30 kDa. Despite the relatively slow progress
in elucidating how small heat shock proteins work, they
have been implicated in many different cellular processes,
such as the suppression of protein aggregation, cytoskele-
tal protein dynamics, cellular growth, transcription and dif-
ferentiation. Of the six known human small heat shock
proteins, some are widely expressed, whereas others are
expressed in only one or two tissues. This difference in
expression pattern suggests that small heat shock proteins
may have general as well as specialised cellular functions.
Whatever the functions of small heat shock proteins might
be, they are likely to involve at some level the regulation
of protein–protein interaction. It is this chaperone-like
property, arresting the heat-induced unfolding and
aggregation of proteins [1], which the scientific commu-
nity has tended to focus on, testing possible physiological,
as well as non-physiological substrates, in in vitro assays.
More recently, evidence was obtained that small heat
shock proteins might interact cooperatively with members
of the heat shock protein 70 (Hsp70) family [2]. After a
long history of research, two major advances have now
been made in the small heat shock protein field: the first
crystal structure of a small heat shock protein has been
determined, and intermediate filaments have been identi-
fied as a physiological target of small heat shock proteins.
A comparison of small heat shock protein sequences from
bacteria to man identified a highly conserved region, known
as the α-crystallin domain because of its relationship to the
lens protein of that name. The small heat shock protein
Hsp16.5 from Methanococcus jannaschii consists almost
entirely of an α-crystallin domain, and the crystal structure
of this small heat shock protein has recently been deter-
mined [3]. This provides the first atomic-resolution view of
this important domain; the remaining, amino-terminal 32
residues of the protein were disordered in the crystal, so
their structure could not be determined and their role
remains a matter of speculation, not only for this small heat
shock protein, but also for the amino-terminal sequences of
other small heat shock proteins. 
In the crystal structure, Hsp16.5 was seen to form an
oligomer of 24 subunits, indicating that the α-crystallin
domain is involved in formation of multisubunit complexes.
The α-crystallin domain of the lens protein αB-crystallin is
also known to play a part in subunit–subunit binding [4],
though in this case additional amino-terminal sequences
may be required for higher-order complex formation, sug-
gesting that the α-crystallin domain alone may not be suffi-
cient for oligomerisation of every small heat shock protein.
The high conservation of the α-crystallin domain in general,
and certain residues in particular, should make it possible to
model the structure of this part of other small heat shock
proteins. Such models should not only fire the enthusiasm
of those in the field, but also direct the analysis of mutations
to study their structure and chaperone activities.
The importance of particular residues within the 
α-crystallin domain has been demonstrated by recent
genetic evidence that mutations in two human homo-
logues of Hsp16.5, αA-crystallin and αB-crystallin, are
responsible for genetic disorders. In αA-crystallin, substi-
tution of arginine 116 by cysteine was found to be the
cause of autosomal dominant congenital cataract [5]. And
in αB-crystallin, substitution of arginine 120 by glycine
(R120G) was found to be the cause of another autosomal
dominant disease, desmin-related myopathy [6]. Both of
these small heat shock proteins are very abundantly
expressed in the eye lens, and indeed the αB-crystallin
mutation also caused cataracts. But whereas αA-crystallin
is specifically expressed in the eye lens, αB-crystallin is
also expressed in many other tissues and is particularly
abundant in muscle. Although the mutations involve two
separate small heat shock proteins, they both affect the
same conserved arginine in the α-crystallin domain, equiv-
alent to arginine 107 in M. jannaschii Hsp16.5.
In the Hsp16.5 crystal structure [3], arginine 107 is seen to
play an unusual role, as it is highly charged yet largely
buried in the hydrophobic protein core, instead of being
exposed on the surface of the β sheet (Figure 1a,b). It
appears that the position of the arginine 107 side chain is
rigidly defined within the structure. The aliphatic side
chain has the hydrophobic properties required for accom-
modation in the local environment of the protein core.
The charged guanidinium group, however, forms a bifur-
cated hydrogen bond with the carbonyl oxygen of glycine
41 in the backbone of the loop between β1 and β2
(Figure 1a,b) and is about 50% accessible on the subunit
surface (Figure 1c). The major effect of these interactions
is that the placing of arginine 107 in the structure is highly
constrained, adding to the internal ‘glue’ of the β sheet
arrangement and certainly determining the position of the
β1–β2 loop. This would make the arginine an ideal con-
tributor to substrate binding, as little entropy would be
lost upon binding. 
In the Hsp16.5 structure, arginine 107 is not directly
involved in subunit–subunit interactions within the
24-subunit oligomer [3]. This conclusion is supported by
the observation that this residue was not mutated in any of
a series of αB-crystallin mutants that cannot assemble into
oligomers, and even when the R120G mutation was intro-
duced it did not disrupt subunit–subunit binding in a yeast
two-hybrid assay [4]. Whether this arginine is directly
involved in substrate binding, or whether it stabilises the
protein structure and in this way influences the protein’s
putative chaperone activity, remains to be experimentally
verified. Nevertheless, combining structural details on the
conserved arginine with information on diseases caused by
its mutation should illuminate the aetiology of the diseases
and the cellular role and target of small heat shock proteins.
The genetic results show that the conserved arginine
plays a very important role in the function of small heat
shock proteins. It also indicates where in the body these
small heat shock proteins have an essential function. The
correlation of the αA-crystallin mutation with the cataract
phenotype confirms a key role for αA-crystallin in the
lens. This had already been strongly suggested by the
analysis of mice lacking αA-crystallin, which developed
cataract and showed inclusion bodies containing αB-crys-
tallin in their lenses [7]. The analogy even goes further in
that patients with the αA-crystallin mutation, like the 
αA-crystallin knock-out mice, suffer from microphthalmia,
suggesting that αA-crystallin might have a role in eye
development. Although αB-crystallin is much more
widely expressed, the genetic results are consistent with
the view that its function is most prominent in those
tissues where it is expressed at the highest level: cardiac
and skeletal muscle and the lens.
Perhaps the most interesting feature of the genetic data is
that now something important can be learnt about the
physiological substrates of small heat shock proteins.
Unfortunately, no detailed information is available about
the way in which cataracts are formed in families carrying
αA-crystallin mutations, but luckily more information is
available from myopathy patients carrying the αB-crystallin
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Figure 1
(a,b) Two views of the monomer structure of
Hsp16.5 from Methanococcus jannaschii are
shown with the backbone in orange (graphics
generated using software InsightII, MSI). The
important residue arginine 107 is highlighted
in magenta, and the β1–β2 loop is green.
Note that the arginine 107 side chain is
directed inwards from the β sheet towards the
hydrophobic core of the protein (a), but that
the charged end group reaches the surface
by pointing sideways to the edge of the
sheet (b). The bifurcated hydrogen bonds
between the charged guanidinium group of
arginine 107 and the carbonyl oxygen of
glycine 41 are represented by the dotted
lines. (c) The solvent accessible surface of an
Hsp16.5 subunit, calculated using GRASP
[13]. Arginine 107 is highlighted in magenta
and the β1–β2 loop is green, showing that
about half of the arginine charged end group
is accessible on the surface. 
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mutation. Biopsies of these patients’ muscles revealed
aggregates of the intermediate filament desmin associated
with αB-crystallin. This very interesting observation con-
firms previous indications that small heat shock proteins
interact with intermediate filaments, both in normal and
pathological situations. Lens cells have a unique cytoskele-
tal element called the beaded filament, which has a back-
bone of intermediate filament protein decorated with
α-crystallin particles [8]. αB-crystallin also associates with
intermediate filaments in cells after stress [9], as well as in
several other pathologies, such as Alexander’s disease and
alcoholic hepatitis. 
This type of interaction appears to be fundamental to the
function of both intermediate filaments and small heat
shock proteins. Mutations in the intermediate filament
protein desmin also cause a desmin-related myopathy
involving the aggregation of intermediate filaments
[10,11] and the aggregates most certainly contain small
heat shock proteins, as is found to be the case in many
desmin-related pathologies [6,12]. These associated small
heat shock proteins cannot prevent intermediate filament
aggregate formation, as similar disease phenotypes result
from both desmin and αB-crystallin mutations. These
results clearly identify intermediate filaments as a physio-
logical target for the chaperone activity of the small heat
shock proteins. 
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